Ketamine is creating new pathways to pain management and better mental health. We present a complete exploration of ketamine at the intersection of clinical care, research and investment, featuring the world’s top researchers, clinicians, companies, advocates and experts.
Discover the potential of ketamine and NMDA receptor antagonists in the treatment of key mental and physical conditions through keynote presentations, expert panels, interactive discussions and collaboration. This two-day conference brings together experts in the field to discuss the very latest science, health care innovation and business opportunities in this rapidly growing field.
Bexson Biomedical – developing therapies for chronic and acute pain management.
The Conscious Fund – investing in early-stage ventures in plant-based medicine.
Microdose – psychedelic insights, events, podcasts, news and market intelligence.
Ketamine Media – a global leader in helping providers raise awareness about the clinical use of ketamine.
What are Molecular Masterclasses?
We sit down with key scientists, advocates and thought leaders to take you on a journey through the psychedelic substances making headlines.